Scientific Advisory Board


Nephrologist and Director of Hemodialysis at St. Michael's Hospital, Toronto, and a Professor of Medicine at the University of Toronto, focusing on critical care nephrology and maintenance dialysis. He led the STARRT-AKI trial on dialysis initiation in acute kidney injury and is part of the PHOSPHATE trial leadership.

Glenn M. Chertow, MD, MPH

Expert in acute kidney failure and chronic kidney disease with more than 30 years of clinical experience. Dr. Chertow has conducted sponsored and NIH-funded trials throughout his career and maintained a research program devoted to improving kidney patient treatment.

Jeffrey L. Winters, MD

Professor of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic. Editor-in-Chief, Journal of Clinical Apheresis and expert in the field of Apheresis.

Patrick M. Moriarty

Director of the Atherosclerosis & Lipid Apheresis Center, Associate Professor of Internal Medicine, University of Kansas Medical Center.

Daniel Keizman, MD

Head of Genitourinary Oncology Unit at Tel Aviv Sourasky Medical Center. Highly involved in oncological clinical research, including research on Galectin 3 and prostate cancer.

David Sachs, MD

Paul S. Russell/Warner Lambert Professor of Surgery at Harvard Medical School and Director of the Transplantation Biology Research Center Laboratories at MGH. With the aim of advancing the field of transplantation science, he focuses on studying the major histocompatibility complex (MHC) and finding strategies to mitigate Graft-versus-Host Disease (GVHD).

Join us in fighting life-threatening diseases.
Learn more about our current investment programs.